Literature DB >> 6538948

Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias).

A Barbeau.   

Abstract

In this essay we first review the important contributions of Dr. George Cotzias to the understanding of chronic manganese intoxication and of manganese metabolism in man and animals. We also indicate the original contribution of Dr. John Donaldson to the mechanism of the neurotoxicity of manganese. In a second phase, the author challenges the tenet that Parkinson's disease is a form of chronic manganese intoxication and that manganism is an experimental model for Parkinson's disease. Clinical, pathological, experimental and biochemical evidence are brought to bear on this argument. Thirdly the author proposes that the necessary event to the so-called "depigmentation" of the substantia nigra and subsequent bradykinetic "low dopamine" syndrome is an early enhanced turnover of dopamine. Manganese intoxication is only one of the factors which may serve as a trigger to this event. Many others are also listed. In opposition to current views, who look for causal factors in Parkinson's disease along the pathways for melanogenesis, the author thus proposes a novel hypothesis which envisions a variety of transient "trigger factors" acting at the dopamine synapse to increase dopamine turnover. In turn, this increased synthesis of dopamine favours the production of large quantities of free radicals within the cell bodies in the substantia nigra, eventually overflowing the scavenging capacity of neuromelanin and their protective barrier, and causing cell death. The resulting decreased pool of dopamine-producing cells leads to a self-perpetuating situation of ever increasing demand on the remaining cells, and "progression" of the disease. Finally the author stresses the fact that genetic factors may play a role in an individual's susceptibility to such triggers. Again defective manganese transport, metabolism or binding are only some of the mechanisms possibly underlying such genetic predisposition to induced basal ganglia disorders. Further studies relating to manganese in these disorders and particularly in Parkinson's disease should focus not on the "intoxication" part of the overload and its striatopallidal consequences, but on the intimate mechanism of destabilization of the homeostatic regulator in neuromelanin bearing cells, even after the exposure period.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6538948

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  69 in total

Review 1.  Cerebral magnetic resonance imaging in patients with chronic liver disease.

Authors:  M Y Morgan
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy.

Authors:  Laurent Spahr; Pierre R Burkhard; Hannelore Grötzsch; Antoine Hadengue
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

3.  Manganese-enhanced magnetic resonance imaging (MEMRI).

Authors:  Cynthia A Massaad; Robia G Pautler
Journal:  Methods Mol Biol       Date:  2011

4.  GPR30 regulates glutamate transporter GLT-1 expression in rat primary astrocytes.

Authors:  Eunsook Lee; Marta Sidoryk-Wêgrzynowicz; Ning Wang; Anton Webb; Deok-Soo Son; Kyuwon Lee; Michael Aschner
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

5.  Olfactory uptake of manganese requires DMT1 and is enhanced by anemia.

Authors:  Khristy Thompson; Ramon M Molina; Thomas Donaghey; James E Schwob; Joseph D Brain; Marianne Wessling-Resnick
Journal:  FASEB J       Date:  2006-11-20       Impact factor: 5.191

Review 6.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

7.  Steel dust in the New York City subway system as a source of manganese, chromium, and iron exposures for transit workers.

Authors:  Steven N Chillrud; David Grass; James M Ross; Drissa Coulibaly; Vesna Slavkovich; David Epstein; Sonja N Sax; Dee Pederson; David Johnson; John D Spengler; Patrick L Kinney; H James Simpson; Paul Brandt-Rauf
Journal:  J Urban Health       Date:  2005-02-28       Impact factor: 3.671

Review 8.  New developments in magnetic resonance imaging of the brain.

Authors:  Alan P Koretsky
Journal:  NeuroRx       Date:  2004-01

9.  Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain.

Authors:  M Yamada; S Ohno; I Okayasu; R Okeda; S Hatakeyama; H Watanabe; K Ushio; H Tsukagoshi
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Varied metal-binding properties of lipoprotein PsaA in Streptococcus pneumoniae.

Authors:  Nan Li; Xiao-Yan Yang; Zhong Guo; Jing Zhang; Kun Cao; Junlong Han; Gong Zhang; Langxia Liu; Xuesong Sun; Qing-Yu He
Journal:  J Biol Inorg Chem       Date:  2014-02-20       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.